AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30360637 — intervention group
Group type: EXPERIMENTAL
Intervention: Wood smoke exposure (500 μg/cm3)
Number of subjects: 39
Study 30360637 — intervention group
Group type: COMPARATOR
Intervention: Filtered air (control)
Number of subjects: 39
Study 28380672 — intervention group
Group type: EXPERIMENTAL
Intervention: Active DBS
Number of subjects: 10
Study 28380672 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 10
Study 23932139 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-chain inulin (20g/L) added to low-fat yogurt
Number of subjects: 0
Study 23932139 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei ssp. paracasei added to low-fat yogurt
Number of subjects: 0
Study 23932139 — intervention group
Group type: COMPARATOR
Intervention: Full-fat yogurt
Number of subjects: 0
Study 21282579 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive-addition lenses (PALs) with a +2.00-D addition
Number of subjects: 118
Study 21282579 — intervention group
Group type: COMPARATOR
Intervention: Single-vision lenses (SVLs)
Number of subjects: 118
Study 19967885 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis
Number of subjects: 1400
Study 19967885 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic prophylaxis
Number of subjects: 1400
Study 17403972 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) guided self-care
Number of subjects: 85
Study 17403972 — intervention group
Group type: COMPARATOR
Intervention: Family therapy
Number of subjects: 85
Study 15379418 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients with acute ketoacidosis
Number of subjects: 38
Study 15379418 — intervention group
Group type: COMPARATOR
Intervention: Healthy children (control group)
Number of subjects: 38
Study 15379418 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients with pH > or =7.0
Number of subjects: 38
Study 11174349 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 18
Study 11174349 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 9569984 — intervention group
Group type: EXPERIMENTAL
Intervention: Bare incisors
Number of subjects: 15
Study 9569984 — intervention group
Group type: COMPARATOR
Intervention: Capped incisors
Number of subjects: 15
Study 9569984 — intervention group
Group type: COMPARATOR
Intervention: Bare molars
Number of subjects: 15
Study 8312766 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy
Number of subjects: 8000
Study 2973588 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime + amikacin (CA)
Number of subjects: 212
Study 2973588 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime + pefloxacin (CP)
Number of subjects: 212
Study 2973588 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime + pefloxacin (CP) and Ceftazidime + amikacin (CA)
Number of subjects: 212
Study 30935010 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein/glucose shake
Number of subjects: 35
Study 30935010 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of white bread and sour milk cheese (food)
Number of subjects: 35
Study 30935010 — intervention group
Group type: COMPARATOR
Intervention: Nothing (control)
Number of subjects: 35
Study 28520812 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) activated with calcium chloride and bovine thrombin, placed into the osteotomy at the time of surgery.
Number of subjects: 64
Study 28520812 — intervention group
Group type: COMPARATOR
Intervention: Saline lavage of the osteotomy (Control group).
Number of subjects: 64
Study 25530603 — intervention group
Group type: EXPERIMENTAL
Intervention: School support (school fees, uniforms, school supplies, school-based helper)
Number of subjects: 328
Study 25530603 — intervention group
Group type: COMPARATOR
Intervention: Control group (delayed partial treatment of school fees only)
Number of subjects: 328
Study 23400614 — intervention group
Group type: EXPERIMENTAL
Intervention: School-Based Asthma Therapy (SBAT) program - administration of 1 dose of preventive asthma medication at school by the school nurse each school day.
Number of subjects: 525
Study 23400614 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 525
Study 20830497 — intervention group
Group type: COMPARATOR
Intervention: inlay without fiber post (G1)
Number of subjects: 70
Study 20830497 — intervention group
Group type: EXPERIMENTAL
Intervention: inlay with long fiber post (G2)
Number of subjects: 70
Study 20830497 — intervention group
Group type: EXPERIMENTAL
Intervention: inlay with short fiber post (G3)
Number of subjects: 70
Study 20830497 — intervention group
Group type: EXPERIMENTAL
Intervention: onlay without fiber post (G4)
Number of subjects: 70
Study 20830497 — intervention group
Group type: EXPERIMENTAL
Intervention: onlay with long fiber post (G5)
Number of subjects: 70
Study 20830497 — intervention group
Group type: EXPERIMENTAL
Intervention: onlay with short fiber post (G6)
Number of subjects: 70
Study 20830497 — intervention group
Group type: COMPARATOR
Intervention: intact teeth (control)
Number of subjects: 70
Study 19108788 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 1% ophthalmic solution
Number of subjects: 48
Study 19108788 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 0.5% ophthalmic solution
Number of subjects: 48
Study 19108788 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (Azithromycin and Moxifloxacin)
Number of subjects: 48
Study 17414766 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mL of contrast material (350 mg of Iodine per milliliter)
Number of subjects: 60
Study 17414766 — intervention group
Group type: COMPARATOR
Intervention: 50 mL of contrast material (350 mg of Iodine per milliliter)
Number of subjects: 60
Study 17414766 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast volume > 0.9 mL/kg body weight
Number of subjects: 60
Study 15355127 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil 500 mg twice daily
Number of subjects: 19
Study 15355127 — intervention group
Group type: COMPARATOR
Intervention: Control group (without mycophenolate mofetil)
Number of subjects: 19
Study 11436969 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray and eye drops
Number of subjects: 99
Study 11436969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 9752515 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial chemotherapy followed by locoregional treatment (Group B, n = 134)
Number of subjects: 272
Study 9752515 — intervention group
Group type: COMPARATOR
Intervention: Mastectomy and axillary node dissection (Group A, n = 138)
Number of subjects: 272
Study 9752515 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival rate at 10 years
Number of subjects: 272
Study 7826821 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine sulphate 600 mg
Number of subjects: 22
Study 7826821 — intervention group
Group type: COMPARATOR
Intervention: Control (non-diabetic)
Number of subjects: 22
Study 3288172 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Electric Stimulation (FES)
Number of subjects: 36
Study 3288172 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy with Biofeedback (BFB) and FES
Number of subjects: 36
Study 3288172 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study 3288172 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback (BFB)
Number of subjects: 36
Study 29992264 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized classification and framework for reporting medication non-adherence
Number of subjects: 0
Study 28592458 — intervention group
Group type: EXPERIMENTAL
Intervention: WARM (37.6°C)
Number of subjects: 8
Study 28592458 — intervention group
Group type: COMPARATOR
Intervention: COOL (29.4°C)
Number of subjects: 8
Study 24438385 — intervention group
Group type: EXPERIMENTAL
Intervention: Restorative home-care service
Number of subjects: 750
Study 23086792 — intervention group
Group type: EXPERIMENTAL
Intervention: Transendocardial injection of bone marrow-derived mononuclear cells (BMC)
Number of subjects: 12
Study 23086792 — intervention group
Group type: COMPARATOR
Intervention: Matched control group from LIPSIAbciximab-STEMI trial
Number of subjects: 12
Study 19175512 — intervention group
Group type: EXPERIMENTAL
Intervention: Insuflon (subcutaneous injection port)
Number of subjects: 66
Study 19175512 — intervention group
Group type: EXPERIMENTAL
Intervention: Alarmable blood glucose meter
Number of subjects: 66
Study 19175512 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 66
Study 17151799 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill walking (TW) program
Number of subjects: 10
Study 17151799 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular physical education curriculum)
Number of subjects: 10
Study 15860712 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 g PUFA daily
Number of subjects: 80
Study 15860712 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 11915059 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine (group B)
Number of subjects: 30
Study 11915059 — intervention group
Group type: COMPARATOR
Intervention: saline (group S)
Number of subjects: 30
Study 9661647 — intervention group
Group type: EXPERIMENTAL
Intervention: iv arginine infusion (30 g) over 30 min
Number of subjects: 14
Study 9661647 — intervention group
Group type: EXPERIMENTAL
Intervention: oral L-dopa (500 mg)
Number of subjects: 14
Study 9661647 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline GH for the entire group
Number of subjects: 14
Study 9661647 — intervention group
Group type: COMPARATOR
Intervention: Comparison of GH secretion between low and normal IGF-I levels
Number of subjects: 14
Study 9661647 — intervention group
Group type: EXPERIMENTAL
Intervention: IGF-I and IGF binding protein-3 concentrations during GH stimulation
Number of subjects: 14
Study 8136670 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal of diuretics
Number of subjects: 63
Study 8136670 — intervention group
Group type: COMPARATOR
Intervention: Control group (continued diuretic use)
Number of subjects: 63
Study 2911450 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam
Number of subjects: 267
Study 2911450 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 267
Study 2911450 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study 31254130 — intervention group
Group type: COMPARATOR
Intervention: Placebo (low preformed vitamin A)
Number of subjects: 143
Study 31254130 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A at the recommended dietary allowance (400 μg retinol activity equivalents/day)
Number of subjects: 143
Study 31254130 — intervention group
Group type: EXPERIMENTAL
Intervention: Maize enhanced with β-carotene (2.86 mg/day)
Number of subjects: 143
Study 29176414 — intervention group
Group type: EXPERIMENTAL
Intervention: Oval incision
Number of subjects: 29
Study 29176414 — intervention group
Group type: COMPARATOR
Intervention: Diamond incision
Number of subjects: 29
Study 29176414 — intervention group
Group type: COMPARATOR
Intervention: Inverted V incision
Number of subjects: 29
Study 25438966 — intervention group
Group type: EXPERIMENTAL
Intervention: COMPAS
Number of subjects: 1563
Study 25438966 — intervention group
Group type: EXPERIMENTAL
Intervention: ¡Cuídate!
Number of subjects: 1563
Study 25438966 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 1563
Study 23142485 — intervention group
Group type: EXPERIMENTAL
Intervention: Sounds of crying baby
Number of subjects: 65
Study 23142485 — intervention group
Group type: EXPERIMENTAL
Intervention: Sounds of violence
Number of subjects: 65
Study 21978993 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care (PC) provided immediately (fast-track group)
Number of subjects: 52
Study 21978993 — intervention group
Group type: COMPARATOR
Intervention: Palliative care (PC) provided after 12 weeks (control group)
Number of subjects: 52
Study 22073456 — intervention group
Group type: EXPERIMENTAL
Intervention: Alumina ceramic abutment (CeraAdapt)
Number of subjects: 23
Study 22073456 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconia ceramic abutment
Number of subjects: 23
Study 22073456 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 23
Study 17147808 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel, cisplatin, 5-FU (TCF)
Number of subjects: 71
Study 17147808 — intervention group
Group type: COMPARATOR
Intervention: Epirubicin, cisplatin, 5-FU (ECF)
Number of subjects: 71
Study 12713212 — intervention group
Group type: EXPERIMENTAL
Intervention: After-school dance classes and a family-based intervention to reduce television viewing
Number of subjects: 61
Study 10743869 — intervention group
Group type: EXPERIMENTAL
Intervention: Group no. 1 (substituted toothbrush monthly)
Number of subjects: 20
Study 10743869 — intervention group
Group type: COMPARATOR
Intervention: Group no. 2 (brushed only with the toothbrush provided at T0)
Number of subjects: 20
Study 10743869 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 8716377 — intervention group
Group type: EXPERIMENTAL
Intervention: Alphanumeric paging system
Number of subjects: 0
Study 1558463 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenelzine sulfate
Number of subjects: 74
Study 1558463 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 74
Study 1558463 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 3905054 — intervention group
Group type: EXPERIMENTAL
Intervention: 324 mg of aspirin daily for 12 weeks
Number of subjects: 1266
Study 3905054 — intervention group
Group type: COMPARATOR
Intervention: aortocoronary bypass surgery
Number of subjects: 1266
Study 3905054 — intervention group
Group type: COMPARATOR
Intervention: heparin therapy
Number of subjects: 1266
Study 3905054 — intervention group
Group type: COMPARATOR
Intervention: nitrates, beta-blockers, calcium blockers, fibrinolytic therapy, and coronary angioplasty
Number of subjects: 1266
Study 29804894 — intervention group
Group type: EXPERIMENTAL
Intervention: VRET plus YOH
Number of subjects: 56
Study 29804894 — intervention group
Group type: EXPERIMENTAL
Intervention: VRET plus Propranolol
Number of subjects: 56
Study 29804894 — intervention group
Group type: COMPARATOR
Intervention: VRET plus placebo
Number of subjects: 56
Study 27151322 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed supplementation (30-g brown milled flaxseed daily)
Number of subjects: 44
Study 27151322 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle modification plus flaxseed
Number of subjects: 44
Study 27151322 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle modification alone (Control)
Number of subjects: 44
Study 27151322 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed supplementation
Number of subjects: 44
Study 27151322 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study 24075240 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypromellose drops
Number of subjects: 48
Study 24075240 — intervention group
Group type: EXPERIMENTAL
Intervention: Tears Again™ liposome spray
Number of subjects: 48
Study 24075240 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of hypromellose drops and Tears Again™ liposome spray
Number of subjects: 48
Study 24075240 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 48
Study 24075240 — intervention group
Group type: EXPERIMENTAL
Intervention: Lubricants
Number of subjects: 48
Study 22407618 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + PDT
Number of subjects: 12
Study 22407618 — intervention group
Group type: COMPARATOR
Intervention: SRP
Number of subjects: 12
Study 20683895 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding
Number of subjects: 0
Study 20683895 — intervention group
Group type: COMPARATOR
Intervention: Counseling for formula feeding
Number of subjects: 0
Study 18190815 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity multidisciplinary program of risk factor reduction
Number of subjects: 513
Study 18190815 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 513
Study 18190815 — intervention group
Group type: EXPERIMENTAL
Intervention: Retention rate
Number of subjects: 513
Study 18190815 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient and physician satisfaction
Number of subjects: 513
Study 15920184 — intervention group
Group type: EXPERIMENTAL
Intervention: IV dexamethasone 0.25 mg/kg (D 0.25)
Number of subjects: 168
Study 15920184 — intervention group
Group type: EXPERIMENTAL
Intervention: IV dexamethasone 0.5 mg/kg (D 0.5)
Number of subjects: 168
Study 15920184 — intervention group
Group type: EXPERIMENTAL
Intervention: IV dexamethasone 1.0 mg/kg (D 1)
Number of subjects: 168
Study 15920184 — intervention group
Group type: COMPARATOR
Intervention: Saline (S)
Number of subjects: 168
Study 14519792 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterol ester group (n = 28) consuming croissants and magdalenas enriched with sterol esters (3.2 g/d) for 8 weeks
Number of subjects: 57
Study 14519792 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 29) consuming standard croissants and muffins
Number of subjects: 57
Study 14519792 — intervention group
Group type: COMPARATOR
Intervention: Comparison between SE group and control group
Number of subjects: 57
Study 11051308 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg promethazine
Number of subjects: 12
Study 11051308 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg promethazine
Number of subjects: 12
Study 11051308 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sterile saline)
Number of subjects: 12
Study 8792793 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality assurance interventions
Number of subjects: 16
Study 1418048 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine (oral therapeutic doses)
Number of subjects: 10
Study 6747018 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyldopa (500 to 2000 mg/day)
Number of subjects: 32
Study 6747018 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (80 to 320 mg/day)
Number of subjects: 32
Study 6747018 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 31181395 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical discipline classes identified among Black parents
Number of subjects: 310
Study 31181395 — intervention group
Group type: EXPERIMENTAL
Intervention: Income
Number of subjects: 310
Study 31181395 — intervention group
Group type: EXPERIMENTAL
Intervention: Child gender
Number of subjects: 310
Study 31181395 — intervention group
Group type: EXPERIMENTAL
Intervention: Never-married status
Number of subjects: 310
Study 31181395 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental education
Number of subjects: 310
Study 31181395 — intervention group
Group type: EXPERIMENTAL
Intervention: Neighborhood safety
Number of subjects: 310
Study 31181395 — intervention group
Group type: EXPERIMENTAL
Intervention: Family stress
Number of subjects: 310
Study 30303873 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-port laparoscopy (SPL)
Number of subjects: 125
Study 25440375 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcuminoids (C3 complex®); 1000 mg/day; n=50
Number of subjects: 100
Study 25440375 — intervention group
Group type: COMPARATOR
Intervention: Placebo; n=50
Number of subjects: 100
Study 23020647 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation program
Number of subjects: 0
Study 23020647 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation program
Number of subjects: 0
Study 18801825 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine 25 mg
Number of subjects: 92
Study 18801825 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine 50 mg
Number of subjects: 92
Study 18801825 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine 20 mg
Number of subjects: 92
Study 18801825 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 17432676 — intervention group
Group type: EXPERIMENTAL
Intervention: Western medicine (group A)
Number of subjects: 116
Study 17432676 — intervention group
Group type: COMPARATOR
Intervention: Integrated Chinese and Western medicine (group B)
Number of subjects: 116
Study 17432676 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 116
Study 17432676 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic examination
Number of subjects: 116
Study 16264036 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) at 5-10 cmH2O
Number of subjects: 16
Study 16264036 — intervention group
Group type: COMPARATOR
Intervention: No CPAP
Number of subjects: 16
Study 11916918 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood letting (three phlebotomies of 500 ml at 2-week intervals)
Number of subjects: 100
Study 11916918 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood letting
Number of subjects: 100
Study 11916918 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 100
Study 10972349 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral supplementation and vitamin D dose of 1000 IU/day
Number of subjects: 32
Study 10972349 — intervention group
Group type: COMPARATOR
Intervention: Lower dose of vitamin D (500 IU/day)
Number of subjects: 32
Study 10972349 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm children
Number of subjects: 32
Study 10972349 — intervention group
Group type: COMPARATOR
Intervention: Control children
Number of subjects: 32
Study 9365972 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 0.02 mg.kg‐1
Number of subjects: 41
Study 9365972 — intervention group
Group type: COMPARATOR
Intervention: Saline 0.9%
Number of subjects: 41
Study 1540020 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified peripheral blood polymorphonuclear leucocytes (PMNs) from patients with RA
Number of subjects: 31
Study 1540020 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 31
Study 1540020 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with RA not receiving drugs or receiving only NSAIDs
Number of subjects: 31
Study 1540020 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with RA receiving second line treatment in addition to NSAIDs
Number of subjects: 31
Study 1540020 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with RA
Number of subjects: 31